.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
A breakthrough AMH PCOS blood test has arrived to simplify the diagnosis of Polycystic Ovary Syndrome (PCOS). Redcliffe Labs and Roche Diagnostics India recently launched this diagnostic tool to improve early detection. Consequently, clinicians can now identify Polycystic Ovarian Morphology (PCOM) without relying solely on traditional imaging. This innovation addresses the significant gap in early detection for millions of women across India.
Traditional diagnosis often requires transvaginal ultrasound, which can cause patient discomfort. However, the new blood test offers a minimally invasive alternative that is easier to access. It measures Anti-Müllerian Hormone levels at any point in the menstrual cycle. Therefore, it provides a standardized and cycle-independent approach for healthcare providers. This accuracy ensures that more patients receive timely interventions and proactive hormonal management.
Recent global clinical guidelines from 2023 now recognize AMH as a reliable marker for PCOM in adults. Furthermore, Indian clinical recommendations support this shift towards biochemical markers for easier screening. Studies demonstrate that this method maintains high diagnostic accuracy in diverse populations. Because it reduces the need for specialized imaging, the test improves accessibility in resource-limited settings. Thus, healthcare providers can now manage PCOS cases with greater confidence and speed.
Q1: How does the AMH test compare to traditional ultrasound?
The AMH blood test identifies polycystic morphology by measuring hormone levels instead of counting follicles via imaging. Unlike ultrasound, it is non-invasive and does not depend on the specific phase of the menstrual cycle.
Q2: Who is eligible for this diagnostic tool?
Clinicians recommend this test for adult women showing symptoms of PCOS or those requiring a convenient screening method. It is particularly useful when access to high-quality transvaginal ultrasound is limited or unavailable.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Redcliffe Labs and Roche launch a new AMH-based blood test to simplify PCOS diagnosis and replace ultrasound in India. Learn about its clinical benefits her...
7 months ago
Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today
A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
